My account
Creating an account and signing in will allow you to keep your Decision box results and view them later.
I do not have an account
Provide some personal information and create a user account allowing to save your Decision box results and view them later.
Sign upI already have an account
My account
Creating an account and signing in will allow you to keep your Decision box results and view them later.
Create an account
New patients with hemophilia, starting on therapy: choosing the clotting factor concentrate
To know more, see the PDF version of this Decision Box by clicking here.
-
What is clotting factor concentrate?Learn more
The medication given to help form a clot and stop bleeding
-
Who should consider this treatment?Learn more
Patients with hemophilia A and tendency to bleed.
-
What are the options?Learn more
(see printable version for more details)
- Plasma derived: the clotting factor is taken from human plasma (the yellowish part of whole blood that remains after all of the blood cells are removed), purified, concentrated, and treated to kill known viruses.
- Recombinant: developed using a molecular biology process (animal or human cells are engineered with the human gene and used to produce factor VIII; the factor is then purified and concentrated).
© Laval University and McMaster University, 2014 all rights reserved